These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

930 related items for PubMed ID: 26187126

  • 1. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer.
    Eggemann H, Ignatov T, Burger E, Kantelhardt EJ, Fettke F, Thomssen C, Costa SD, Ignatov A.
    Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J, Kanomata N, Yamashita T, Shimo T, Mizutoh A, Moriya T, Sonoo H.
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey.
    Kuzhan A, Adli M, Eryigit Alkis H, Caglayan D.
    J BUON; 2013 May; 18(3):619-22. PubMed ID: 24065473
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemically defined subtypes and outcome of apocrine breast cancer.
    Dellapasqua S, Maisonneuve P, Viale G, Pruneri G, Mazzarol G, Ghisini R, Mazza M, Iorfida M, Rotmensz N, Veronesi P, Luini A, Goldhirsch A, Colleoni M.
    Clin Breast Cancer; 2013 Apr; 13(2):95-102. PubMed ID: 23245877
    [Abstract] [Full Text] [Related]

  • 9. Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression.
    Balduzzi A, Bagnardi V, Rotmensz N, Dellapasqua S, Montagna E, Cardillo A, Viale G, Veronesi P, Intra M, Luini A, Pruneri G, Mastropasqua G, Goldhirsch A, Colleoni M.
    Clin Breast Cancer; 2014 Aug; 14(4):258-64. PubMed ID: 24325948
    [Abstract] [Full Text] [Related]

  • 10. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
    Stamatovic L, Susnjar S, Gavrilovic D, Minic I, Ursulovic T, Dzodic R.
    J BUON; 2018 Aug; 23(5):1273-1280. PubMed ID: 30570847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hormone receptors and HER2 expression in primary breast carcinoma and corresponding lymph node metastasis: do we need both?
    Raica M, Cîmpean AM, Ceausu RA, Fulga V, Nica C, Rudico L, Saptefrati L.
    Anticancer Res; 2014 Mar; 34(3):1435-40. PubMed ID: 24596391
    [Abstract] [Full Text] [Related]

  • 18. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
    Yang TJ, Morrow M, Modi S, Zhang Z, Krause K, Siu C, McCormick B, Powell SN, Ho AY.
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
    [Abstract] [Full Text] [Related]

  • 19. Receptor discordances after neoadjuvant chemotherapy and their effects on survival.
    Tural D, Karaca M, Zirtiloglu A, M Hacioglu B, Sendur MA, Ozet A.
    J BUON; 2019 Dec; 24(1):20-25. PubMed ID: 30941947
    [Abstract] [Full Text] [Related]

  • 20. Low protein expression of MET in ER-positive and HER2-positive breast cancer.
    Zagouri F, Brandstetter A, Moussiolis D, Chrysikos D, Dimitrakakis C, Tsigginou A, Marinopoulos S, Zografos GC, Sergentanis TN, Dimopoulos MA, Filipits M.
    Anticancer Res; 2014 Mar; 34(3):1227-31. PubMed ID: 24596364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.